Robert Russell
Nurse Practitioner · Dothan, ALNPI 1801286059
Payments from drug & device makers
Across 157 payments — averaging $15.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Dexcom, Inc.$441
- Abbott$278
- AbbVie$190
- GSK$170
- Bayer$155
- AstraZeneca$138
- plus $1K from 30 others
What the payments were for
- Food & beverage$2,45698%
- Other$522%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Dexcom, Inc. | 35 | $441 |
| Abbott | 22 | $278 |
| AbbVie | 9 | $190 |
| GSK | 10 | $170 |
| Bayer | 10 | $155 |
| AstraZeneca | 8 | $138 |
| Lilly USA, LLC | 9 | $107 |
| Pfizer | 5 | $86 |
| Vericel Corporation | 1 | $81 |
| Radius Health, Inc. | 4 | $77 |
| Corcept Therapeutics | 5 | $75 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $66 |
| Medtronic | 2 | $65 |
| Amarin Pharma, Inc. | 4 | $62 |
| Ultragenyx Pharmaceutical Inc. | 2 | $41 |
| Phathom Pharmaceuticals, Inc. | 2 | $41 |
| Astellas Pharma US Inc | 2 | $38 |
| Amgen | 2 | $36 |
| Aurinia Pharma U.S., Inc. | 2 | $34 |
| ANI Pharmaceuticals, Inc. | 2 | $32 |
| Novo Nordisk | 2 | $31 |
| Baxter Healthcare | 1 | $26 |
| Welch Allyn | 1 | $26 |
| Smith+Nephew | 1 | $22 |
| Upsher-smith Laboratories LLC | 1 | $22 |
| Sanofi-aventis U.S. LLC | 1 | $21 |
| Sanofi | 1 | $20 |
| Xeris Pharmaceuticals, Inc. | 1 | $18 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $16 |
| Mallinckrodt Hospital Products Inc. | 1 | $15 |
| Daiichi Sankyo Inc. | 1 | $15 |
| Grifols USA, LLC | 1 | $14 |
| Philips North America LLC | 1 | $14 |
| Alfasigma USA, Inc. | 1 | $12 |
| Recordati_rare_diseases_inc. | 1 | $12 |
| Merck | 1 | $12 |
How this compares
$2,508 in reported general payments places this provider in the 80th percentile of 1,505 nurse practitioner providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 90 | $97,936 |
| MounjaroTirzepatide | 57 | $69,428 |
| JardianceEmpagliflozin | 40 | $31,719 |
| XareltoRivaroxaban | 20 | $30,038 |
| JanuviaSitagliptin Phosphate | 27 | $22,714 |
| EliquisApixaban | 23 | $19,601 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 22 | $18,034 |
| FarxigaDapagliflozin Propanediol | 25 | $15,553 |
| Repatha SureclickEvolocumab | 14 | $12,249 |
| EntrestoSacubitril/Valsartan | 13 | $10,565 |
| Fluticasone Propionate HfaFluticasone Propionate | 11 | $4,900 |
| Humulin 70/30 KwikpenInsulin Nph Hum/Reg Insulin Hm | 11 | $4,175 |
| Humalog Mix 50-50 KwikpenInsulin Lispro Protamin/Lispro | 12 | $3,239 |
| Duloxetine Hcl | 134 | $2,831 |
| Humalog Mix 75-25 KwikpenInsulin Lispro Protamin/Lispro | 16 | $2,475 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $31 | $97,93690 claims |
| Lilly USA, LLCMounjaro, Humulin 70-30 | $107 | $70,19774 claims |
| MerckJanuvia | $12 | $22,71427 claims |
| PfizerEliquis | $86 | $19,60123 claims |
| GSKTrelegy Ellipta | $170 | $18,03422 claims |
| AstraZenecaFarxiga | $138 | $15,55325 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,505 nurse practitioner providers in Alabama.
Other nurse practitioner in Dothan
- Hollie CrutchfieldDothan$22K
- Christina BellDothan$14K
- Shea CalhounDothan$14K
- Amanda PybusDothan$13K
- Tami CaldwellDothan$13K
- Alison HallDothan$12K
- Jennifer ParrishDothan$12K
- Amanda SewellDothan$11K
- Amy EthridgeDothan$11K
- Allison McAllisterDothan$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.